Sign in

James Turley

Director at CITIGROUPCITIGROUP
Board

About James S. Turley

James S. Turley (age 69) is an independent director of Citigroup Inc. and Citibank, N.A., serving since 2013; he is the former Global Chairman and CEO of Ernst & Young (2001–2013), with prior service as Regional Managing Partner (1994–2001) . He is currently Chair of Citi’s Audit Committee and a member of the Risk Management Committee, and is recognized as an SEC “audit committee financial expert” and financially literate under NYSE rules . The Board determined Turley is independent under Citi’s Corporate Governance Guidelines and applicable NYSE, SEC, Federal Reserve, and FDIC standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Ernst & YoungGlobal Chairman & CEO2001–2013Led a major public accounting firm; experience in compensation, litigation, corporate governance; diversity leadership (Catalyst Crystal Leadership Award) .
Ernst & YoungRegional Managing Partner1994–2001Senior operating leadership across U.S. and international markets .
Boy Scouts of AmericaPast ChairNot specifiedNon-profit leadership .
Municipal Theatre Association of St. LouisPast ChairNot specifiedCommunity leadership .
Forest Park ForeverBoard MemberNot specifiedNon-profit board service .
ConcordanceBoard MemberNot specifiedNon-profit board service .

External Roles

CompanyRoleTenure/StatusNotes
Emerson Electric Co.DirectorCurrentListed as other public company directorship .
Northrop Grumman CorporationDirectorCurrentListed as other public company directorship .
Precigen, Inc.DirectorCurrentListed as other public company directorship .
Citibank, N.A.DirectorSince 2013Serves on the bank subsidiary board .

Board Governance

CommitteeRoleMeetings in 2024Key Oversight
Audit CommitteeChair18Financial reporting integrity; internal controls; Internal Audit; independent auditors; control remediation; ESG disclosure controls; Chief Auditor compensation; compliance with legal/regulatory requirements .
Risk Management CommitteeMember16Enterprise Risk Management Framework; key risk policies; oversight of risk profile; GRR function; conduct risk; CRO/CCO access to Board .
  • Board met 26 times in 2024; each incumbent director attended at least 75% of Board and committee meetings of which they were a member; non-management directors met in executive session at each regular Board meeting .
  • Audit Committee Report signed March 14, 2025, with selection of KPMG LLP as independent registered public accounting firm for 2025; committee affirmed auditor independence and recommended inclusion of audited 2024 financial statements in Form 10-K .
  • Audit Committee Report for 2023 signed March 13, 2024, similarly affirming independence and recommending inclusion of audited 2023 financial statements; KPMG selected for 2024 .

Fixed Compensation

YearFees Earned or Paid in Cash ($)Stock Awards ($)Total ($)
2024278,333 150,000 428,333
2023260,000 150,000 410,000
2024 Cash vs Deferred ElectionFees Paid Currently in Cash ($)Deferred Fees in Stock – UnitsDeferred Fees in Stock – Value ($)
James S. Turley278,333

Director fee schedule (context for pay mix):

  • Annual cash retainer: $75,000; annual deferred stock award: $150,000 (generally granted early January; distributable on first anniversary; forfeiture pro rata if resign/retire before age 72) .
  • Committee fees: Chair of Audit/Compensation/Risk/Technology/ad hoc: $50,000; Chair of other committees: $35,000; Members of Audit/Compensation/Risk/Technology/ad hoc: $30,000; Members of Nominating, Governance & Public Affairs (NGPA): $15,000; TOC Chair: $50,000; TOC member: $30,000; TOC Program Lead: $20,000; Citibank, N.A. non-employee director retainer: $25,000; Citibank, N.A. Chair fee: $50,000 .

Program guardrails:

  • Primarily equity-based compensation; no meeting fees; no director retirement program; hedging and pledging of Citi stock prohibited; $1 million annual cap on combined awards and cash fees (exception possible for non-executive Chair) .

Performance Compensation

YearDeferred Stock Granted (#)Grant Date Fair Value ($)Notes
20242,922 150,000 Grant date January 2, 2024; grant price based on avg NYSE closing prices of prior five trading days .
20233,353 150,000 Grant date January 2, 2023; similar pricing methodology .

Performance metric structure for director equity awards:

  • Performance conditions: None disclosed for director deferred stock; awards are time-based with distribution generally on the first anniversary; directors may elect to defer receipt beyond that date .
  • Ownership commitment: Directors must retain 75% of equity awarded while serving on the Board; hedging/pledging prohibited .
  • Award limits: Combined stock awards and cash fees capped at $1 million per calendar year for directors; plan specifies option/SAR pricing at FMV and max 10-year term, but stock options are not indicated as part of director compensation .

Other Directorships & Interlocks

CompanySectorPotential Interlock Context
Emerson Electric Co.Diversified industrialListed as external public board; no related-party transactions disclosed with Citi .
Northrop Grumman CorporationDefenseListed as external public board; Board reviewed relationships and determined independence .
Precigen, Inc.BiotechnologyListed as external public board; Board reviewed relationships and determined independence .
  • Citi’s procedure for related party transactions assigns review to NGPA Committee (or its Chair) and Compensation Committee for employment/compensation-related matters; transactions >$120,000 involving related persons require committee review; Turley does not have disclosed related party transactions with Citi .

Expertise & Qualifications

  • SEC-defined audit committee financial expert; financially literate under NYSE rules; deep experience in financial reporting, regulatory compliance, internal audit, legal matters, and risk management .
  • Diversity advocate (former Chairman of Catalyst board; Crystal Leadership Award for supporting equal marketplace access for women) .

Equity Ownership

DateCommon Stock Beneficially Owned (Excl. Options)Receipt Deferred (Shares)Total Ownership (Shares)
March 3, 202537,515 2,117 39,632
March 4, 202433,390 2,922 36,312
Deferred Stock Outstanding (End of Year)20232024
James S. Turley31,852 35,977
  • No director or executive officer beneficially owned more than 1% of Citi common stock as of March 4, 2024; directors/executives as a group owned ~0.08% .
  • Directors must retain 75% of equity awarded during Board service; hedging and pledging are prohibited by policy .

Governance Assessment

  • Board effectiveness: Turley chairs the Audit Committee and is a designated audit committee financial expert, enhancing oversight of financial reporting, internal controls, and auditor independence; he co-signed Audit Committee reports in 2024 and 2025 that recommended inclusion of audited financials and affirmed auditor independence .
  • Engagement: The Board met 26 times in 2024; Audit met 18 times and Risk met 16; all directors met at least the 75% attendance expectation; Turley also serves on Citibank’s Board, indicating high engagement across core risk and financial control domains .
  • Independence and conflicts: The Board reviewed director relationships and deemed Turley independent; Citi has robust related-party review procedures and no Turley-related party transactions are disclosed; hedging and pledging bans further align director and shareholder interests .
  • Pay-for-performance alignment for directors: Compensation is primarily equity-based via deferred stock awards with time-based distribution and strong ownership retention requirements; no meeting fees or retirement benefits; caps limit pay inflation risk .

RED FLAGS: None disclosed specific to Turley—no related-party transactions, no legal proceedings adverse to Citi, and policy prohibits pledging/hedging of Citi stock .

Contextual observation: Turley serves on three external public boards in addition to Citi, within Citi’s guideline limit (≤ five for-profit boards; audit committee members limited to ≤ three audit committees), and the Board annually evaluates outside commitments and determined nominees can devote sufficient time .